NABP Invited to Discuss Best Practices for Restricted TLDs With US Intellectual Property Enforcement Coordinator
![Icon of newspaper](https://nabp.pharmacy/wp-content/uploads/2021/03/News-Icons-Newspaper.png)
The Office of the United States Intellectual Property Enforcement Coordinator held a meeting to discuss the implementation of restricted new generic Top-Level Domains (gTLDs). The objective of the meeting, held on March 15, 2016, was to address the issues impacting restricted gTLDs, such as best practices in operations, consumer awareness, and public policy. Carmen A. […]
Read More ›NABP 112th Annual Meeting to Set Sail in ‘America’s Finest City’ for Important Business Sessions, Timely CPE Programs, and Unique Networking Events
![Icon of newspaper](https://nabp.pharmacy/wp-content/uploads/2021/03/News-Icons-Newspaper.png)
Set in San Diego, CA, a city known for its sunny weather and Pacific coastline views, the National Association of Boards of Pharmacy® (NABP®) 112th Annual Meeting, “All Hands on Deck – Forging Ahead to a New Regulatory World,” will provide attendees an opportunity to explore “America’s Finest City” after participating in important NABP Business […]
Read More ›Three Additional States Sign Agreement to Participate in NABP PMP InterConnect
The Alaska Prescription Drug Monitoring Program (PDMP), Maine Prescription Monitoring Program (PMP), and Montana Prescription Drug Registry recently executed a memorandum of understanding (MOU) to participate in NABP PMP InterConnect®, joining 31 other state PMPs who have agreed to participate. To date, 30 of these state PMPs – Arizona, Arkansas, Colorado, Connecticut, Delaware, Idaho, Illinois, […]
Read More ›Minnesota Board Uses PMP Data to Alert Prescribers of Potential Misuse, Support Assistance for Patients
![Icon of Lightbulb](https://nabp.pharmacy/wp-content/uploads/2021/03/News-Icons-Lightbulb.png)
After 10 months of sending unsolicited notices to about 2,400 health care providers alerting them of patients who might be “doctor shopping,” the Minnesota Board of Pharmacy found that 88% percent of these patients dropped off the alert list within one month after their prescribers were notified. The Board used the state’s prescription monitoring program […]
Read More ›AWARXE Prescription Drug Safety Program Launches a Redesigned Website, Site Granted a .Pharmacy Domain
The AWARXE® Prescription Drug Safety Program is pleased to announce the relaunch of its website to provide consumers and pharmacists with an easier way to find timely and relevant information on preventing the misuse and abuse of prescription drugs. In addition to the new look and easier navigation, the site has a new address: www.awarerx.pharmacy. […]
Read More ›PMP InterConnect Integration Projects Bring Data Into Pharmacy Workflow, Ohio Supports Additional Deployments With $1.5 M In Funding
![Icon of newspaper](https://nabp.pharmacy/wp-content/uploads/2021/03/News-Icons-Newspaper.png)
Recognizing the importance of expanding the use of prescription monitoring program (PMP) data in pharmacists’ workflow to enhance prescription drug abuse and diversion prevention efforts, NABP has been working to integrate other PMP services with NABP PMP InterConnect®. Most recently, PMP Gateway – a service that works in tandem with PMP InterConnect – has been […]
Read More ›NABP Meets With Leaders Around the World to Collaborate on Solutions for Protecting Consumers From Illegal Online Drug Sellers
![Icon of Lightbulb](https://nabp.pharmacy/wp-content/uploads/2021/03/News-Icons-Lightbulb.png)
Today, the National Association of Boards of Pharmacy® (NABP®) issued a report discussing the importance of international collaboration in the fight against illegal online drug sellers. As detailed in the Internet Drug Outlet Identification Program Progress Report for State and Federal Regulators: October 2015, there is widespread agreement among multiple countries that Internet sales of […]
Read More ›NABP Supports Increasing Compounding Safety With Qualified Person Credentialing Program
With the goal of increasing compounding safety, CriticalPoint, LLC, has launched the Qualified Persons Credentialing Program (QPCP) for pharmacists at entities practicing compounding under sections 503A and 503B of the Drug Quality and Security Act (DQSA), Title I – Compounding Quality Act. NABP strongly believes that these pharmacists should be able to demonstrate knowledge, design […]
Read More ›Pharmacy Automation Distributor Application Now Available for .Pharmacy
NABP is offering pharmacy automation distributors the opportunity to apply for, and if approved, register a .pharmacy Top-Level Domain (TLD) through the Association’s .Pharmacy TLD Program. Pharmacy automation involves the mechanical processes of storing and dispensing medications. Distributors of pharmacy automation must provide licensure and certification information, if applicable, in addition to other corporate information […]
Read More ›Pharmacy Stakeholders Worldwide to Share Practice Information During FIP 2015 Congress, NABP to Present
![Icon of Lightbulb](https://nabp.pharmacy/wp-content/uploads/2021/03/News-Icons-Lightbulb.png)
Practitioners, researchers, and academics worldwide will gather to help shape modern pharmacy practice during the 75th International Pharmaceutical Federation (FIP) World Congress of Pharmacy and Pharmaceutical Sciences 2015. Held from September 29 to October 3, 2015, in Düsseldorf, Germany, the congress will focus on how to make evidence-based pharmaceutical science the driving force of modern […]
Read More ›